Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
Medical center in Mountain View, California
701 E El Camino Real, Mountain View, CA 94040
About Palo Alto Medical Foundation-Camino Division
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
75
SWOG Cancer Research Network
27
Alliance for Clinical Trials in Oncology
15
ECOG-ACRIN Cancer Research Group
7
GOG Foundation
4
NRG Oncology
4
Gynecologic Oncology Group
3
Alliance Foundation Trials, LLC.
1
ETOP IBCSG Partners Foundation
1
Medtronic - MITG
1
Medtronic Surgical Technologies
1
Clinical Trials at Palo Alto Medical Foundation-Camino Division
During the past decade, Palo Alto Medical Foundation-Camino Division conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 67 clinical trials were completed, i.e. on
average, 94.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 40 clinical trials were completed. i.e. 222.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
2004-06-15
2008-01-08
Completed
55
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Camino Division" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 27 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "GOG Foundation"
with 7 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Camino Division"
#1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 27 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at Palo Alto Medical Foundation-Camino Division
According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Camino Division" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Camino Division" in a lesser frequency.
Clinical Trials Intervention Types at Palo Alto Medical Foundation-Camino Division
Most popular intervention types in "Palo Alto Medical Foundation-Camino Division" are "Drug" (116 trials), "Other" (96 trials), "Biological" (60 trials), "Procedure" (36 trials) and "Radiation" (15 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (20 trials), "Biospecimen Collection" (17 trials) and "Paclitaxel" (17 trials). Other intervention names were less common.
Clinical Trials Genders at Palo Alto Medical Foundation-Camino Division
The vast majority of trials in "Palo Alto Medical Foundation-Camino Division" are
107 trials for "All" genders, 31 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Palo Alto Medical Foundation-Camino Division
Currently, there are NaN active trials in "Palo Alto Medical Foundation-Camino Division".
undefined are not yet recruiting,
26 are recruiting,
72 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 31 completed trials in Palo Alto Medical Foundation-Camino Division,
3 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Palo Alto Medical Foundation-Camino Division, 3 "Phase 1"
clinical trials were conducted, 71 "Phase 2" clinical
trials and 79 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".